Transient Contrast Neurotoxicity After Percutaneous Coronary Intervention Mimicking Subarachnoid Hemorrhage in a Patient With Chronic Kidney Disease
Author(s) -
Şimşek Ersin Çagri,
Ertürk Elif,
Uçar Roza,
Yilmaz Artun Onat,
Ekmekçi Cenk,
Mutlu İnan,
Sari Cenk
Publication year - 2019
Publication title -
clinical medicine insights: case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.187
H-Index - 12
ISSN - 1179-5476
DOI - 10.1177/1179547619867671
Subject(s) - medicine , neurotoxicity , hemodialysis , encephalopathy , kidney disease , complication , subarachnoid hemorrhage , contrast induced nephropathy , contrast medium , percutaneous coronary intervention , surgery , radiology , anesthesia , toxicity , myocardial infarction
Transient contrast neurotoxicity is a rare but well-recognized complication of angiography that is due to neurotoxicity of the contrast agent. Patients with renal dysfunction may be inclined to develop contrast medium neurotoxicity due to delayed elimination of the contrast medium in renal metabolism. In this report, we present an unusual case of transient neurotoxicity in a patient with severe chronic kidney disease following percutaneous coronary intervention mimicking clinically and radiologically subarachnoid hemorrhage. The patient’s clinical symptoms improved rapidly and fully recovered after hemodialysis and conservative treatment. We believe that performing early hemodialysis is an effective treatment to improve symptoms in end-stage renal disease patients with contrast-induced encephalopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom